AXSOME THERAPEUTICS INC (AXSM) Stock Analyst Earnings Estimates
NASDAQ:AXSM - Nasdaq - US05464T1043 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 50.04M | 270.6M 440.77% | 385.693M 42.53% | 627.04M 62.57% | 1.003B 59.96% | 1.54B 53.54% | 2.069B 34.35% | 2.613B 26.29% | 3.041B 16.38% | 3.071B 0.99% | 3.452B 12.41% | |
| EBITDA YoY % growth | -174.9M -40.34% | -224.991M -28.64% | -272.604M -21.16% | -140.627M 48.41% | 148.35M 205.49% | 537.63M 262.41% | 802.23M 49.22% | 1.196B 49.08% | 1.255B 4.93% | 1.479B 17.85% | N/A | |
| EBIT YoY % growth | -179.3M -43.77% | -231.825M -29.29% | -280.562M -21.02% | -155.469M 44.59% | 113.97M 173.31% | 581.86M 410.54% | 927.2M 59.35% | 1.46B 57.46% | 1.84B 26.03% | 1.619B -12.01% | 1.786B 10.32% | |
| Operating Margin | -358.31% | -85.67% | -72.74% | -24.79% | 11.36% | 37.78% | 44.81% | 55.87% | 60.51% | 52.72% | 51.74% | |
| EPS YoY % growth | -4.57 -31.70% | -5.20 -13.79% | -5.99 -15.19% | -3.64 39.19% | 1.52 141.68% | 9.21 506.59% | 12.78 38.79% | 19.74 54.41% | 27.32 38.43% | 19.31 -29.33% | 19.71 2.06% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.13 32.43% | -0.83 37.74% | -0.52 66.30% | -0.48 61.02% | 0.19 116.57% | 0.89 206.78% | 1.58 403.69% |
| Revenue Q2Q % growth | 142.1M 63.02% | 164.8M 57.31% | 191.09M 60.90% | 185.79M 52.96% | 230.54M 62.24% | 278.55M 69.02% | 326.62M 70.92% |
| EBITDA Q2Q % growth | -59.255M 20.16% | -35.102M 38.13% | -14.593M 77.43% | 29.998M 152.49% | 74.491M 225.71% | 92.973M 364.87% | 111.28M 862.57% |
| EBIT Q2Q % growth | -51.737M 33.71% | -37.495M 40.13% | -21.227M 70.77% | -25.534M 56.93% | 20.969M 140.53% | 54.149M 244.42% | 81.327M 483.12% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -1.22 15.28% | -1.35 | 0.13 | 9.80% |
| Q4 2024 Q2Q % growth | -1.54 25.96% | -1.04 | -0.50 | -48.67% |
| Q3 2024 Q2Q % growth | -1.34 -1.52% | -1.44 | 0.10 | 6.83% |
| Q2 2024 Q2Q % growth | -1.67 -8.44% | -1.36 | -0.31 | -22.89% |
| Q1 2024 Q2Q % growth | -1.44 -453.85% | -1.23 | -0.21 | -17.22% |
| Q4 2023 Q2Q % growth | -2.08 -47.52% | -1.19 | -0.89 | -74.11% |
| Q3 2023 Q2Q % growth | -1.32 -23.36% | -1.23 | -0.09 | -7.52% |
| Q2 2023 Q2Q % growth | -1.54 -45.28% | -1.25 | -0.29 | -23.51% |
| Q1 2023 Q2Q % growth | -0.26 74.76% | -1.06 | 0.80 | 75.39% |
| Q4 2022 Q2Q % growth | -1.41 -56.67% | -1.16 | -0.25 | -21.43% |
| Q3 2022 Q2Q % growth | -1.07 -15.05% | -1.10 | 0.03 | 2.80% |
| Q2 2022 Q2Q % growth | -1.06 -23.26% | -1.23 | 0.17 | 13.97% |
| Q1 2022 Q2Q % growth | -1.03 -32.05% | -1.02 | -0.01 | -0.75% |
| Q4 2021 Q2Q % growth | -0.90 -15.38% | -1.04 | 0.14 | 13.63% |
| Q3 2021 Q2Q % growth | -0.93 -60.34% | -0.97 | 0.04 | 4.06% |
| Q2 2021 Q2Q % growth | -0.86 -75.51% | -0.98 | 0.12 | 12.63% |
| Q1 2021 Q2Q % growth | -0.78 11.36% | -0.88 | 0.10 | 11.84% |
| Q4 2020 Q2Q % growth | -0.78 -9.86% | -0.77 | -0.01 | -0.90% |
| Q3 2020 Q2Q % growth | -0.58 -3.57% | -0.58 | 0.00 | 0.62% |
| Q2 2020 Q2Q % growth | -0.49 -19.51% | -0.63 | 0.14 | 22.07% |
| Q1 2020 Q2Q % growth | -0.88 -175.00% | -0.64 | -0.24 | -38.16% |
| Q4 2019 Q2Q % growth | -0.71 | -0.49 | -0.22 | -45.02% |
| Q3 2019 Q2Q % growth | -0.56 | -0.41 | -0.15 | -36.83% |
| Q2 2019 Q2Q % growth | -0.41 | -0.33 | -0.08 | -23.05% |
| Q1 2019 Q2Q % growth | -0.32 | -0.30 | -0.02 | -5.99% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 121.463M 61.95% | 122.26M | -797K | -0.65% |
| Q4 2024 Q2Q % growth | 118.766M 66.03% | 120M | -1.234M | -1.03% |
| Q3 2024 Q2Q % growth | 104.762M 81.27% | 100.94M | 3.822M | 3.79% |
| Q2 2024 Q2Q % growth | 87.166M 89.42% | 88.66M | -1.494M | -1.69% |
| Q1 2024 Q2Q % growth | 74.999M -20.70% | 74.761M | 238K | 0.32% |
| Q4 2023 Q2Q % growth | 71.531M 193.52% | 68.915M | 2.616M | 3.80% |
| Q3 2023 Q2Q % growth | 57.794M 242.99% | 55.959M | 1.835M | 3.28% |
| Q2 2023 Q2Q % growth | 46.017M 421.73% | 41.753M | 4.264M | 10.21% |
| Q1 2023 Q2Q % growth | 94.576M | 26.591M | 67.985M | 255.67% |
| Q4 2022 Q2Q % growth | 24.37M | 22.195M | 2.175M | 9.80% |
| Q3 2022 Q2Q % growth | 16.85M | 16.968M | -118K | -0.70% |
| Q2 2022 Q2Q % growth | 8.82M | 6.418M | 2.402M | 37.43% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -5.54% | -8.11% | -2.07% | -9.67% |
| Revenue | -0.85% | -0.89% | -0.16% | -0.58% |